Society of Robotic Surgery 2017: State-of-the-Art Lecture: Robotics in Renal Surgery, What’s the Next Frontier? - Session Highlights
Immunologic therapy and angiogenesis-inhibiting drugs have emerged in treating renal tumors. Targeted therapies such as pazopanib in a recent phase III study can be used in advanced or metastatic renal cell carcinoma. Minimally invasive surgical techniques such as radical nephrectomy and PN have become the mainstay in the management of renal masses, and particular robotics have resulted in the increased use of PN.
Presented By: Raju Thomas, MD, Tulane University
Contributed by Stephen B. Williams, MD, Assistant Professor, The University of Texas Medical Branch at Galveston, Galveston, TX
at the 2017 Society of Robotic Surgery - February 24 - 26, 2017 – Miami, Florida USA